Recherche clinique et amélioration de la santé des populationsCHENE, Geneviève.QUESTIONS DE SANTE PUBLIQUE. 2013, Num 22, issn 1967-5615, 4 p.Serial Issue

Vieillir avec le VIH et les trithérapies : VIH, 30 ans aprèsCHENE, Geneviève; RICHERT, Laura.Biofutur (Puteaux). 2011, Num 327, pp 42-43, issn 0294-3506, 2 p.Article

Methodological issues of non-inferiority trials in HIV-infected patients : a need for consensus?RICHERT, Laura; BOUTELOUP, Vincent; THIEBAUT, Rodolphe et al.AIDS (London). 2008, Vol 22, Num 8, pp 996-997, issn 0269-9370, 2 p.Article

Syndrome lipodystrophique et traitements antirétroviraux chez les patients infectés par le VIH-1 = Lipodystrophic syndrome and antiretroviral treatments in HIV-infected patientsSAVES, Marianne; MERCIE, Patrick; CHENE, Geneviève et al.MS. Médecine sciences. 2001, Vol 17, Num 8-9, pp 886-892, issn 0767-0974Article

Is nevirapine-based therapy discontinuation in hepatitis C co-infected patients a more important mortality determinant than hypersensitivityRAFFI, Francois; LEWDEN, Charlotte; CHENE, Geneviève et al.AIDS (London). 2008, Vol 22, Num 3, pp 435-436, issn 0269-9370, 2 p.Article

Brain MRI markers and dropout in a longitudinal study of cognitive aging: The Three-City Dijon StudyGLYMOUR, M. Maria; CHENE, Geneviève; TZOURIO, Christophe et al.Neurology. 2012, Vol 79, Num 13, pp 1340-1348, issn 0028-3878, 9 p.Article

Clinical research infrastructures and networks in France : Report on the French ECRIN workshopDEMOTES-MAINARD, Jacques; CHENE, Geneviève; LIBERSA, Christian et al.Thérapie (Paris). 2005, Vol 60, Num 2, pp 183-199, issn 0040-5957, 17 p.Article

Interaction between HIV-1 and HCV infections: towards a new entity?WINNOCK, Maria; SALMON-CERON, Dominique; DABIS, Francois et al.Journal of antimicrobial chemotherapy (Print). 2004, Vol 53, Num 6, pp 936-946, issn 0305-7453, 11 p.Article

Estimation de la taille de la population toxicomane de l'agglomération toulousaineBELLO, Pierre-Yves; CHENE, Geneviève.1995, 50 p.Book

Clinically informative measures of the effect of drugs or other interventionsSALMI, L. Rachid; SUISSA, Samy; CHENE, Geneviève et al.British journal of clinical pharmacology. 2008, Vol 65, Num 6, pp 935-941, issn 0306-5251, 7 p.Article

Significant differences in DNA viral load between HIV-1 and HIV-2 infected patientsGUEUDIN, Marie; BENARD, Antoine; CHENE, Geneviève et al.AIDS (London). 2008, Vol 22, Num 12, pp 1519-1520, issn 0269-9370, 2 p.Article

A new endpoint definition improved clinical relevance and statistical power in a vaccine trialPEDRONO, Gaëlle; THIEBAUT, Rodolphe; ALIOUM, Ahmadou et al.Journal of clinical epidemiology. 2009, Vol 62, Num 10, pp 1054-1061, issn 0895-4356, 8 p.Article

Use of a bayesian approach to decide when to stop a therapeutic trial : The case of a chemoprophylaxis trial in human immunodeficiency virus infectionKPOZEHOUEN, Alphonse; ALIOUM, Ahmadou; ANGLARET, Xavier et al.American journal of epidemiology. 2005, Vol 161, Num 6, pp 595-603, issn 0002-9262, 9 p.Article

Evaluation of the VERSANT HCV RNA 3.0 assay for quantification of hepatitis C virus RNA in serumTRIMOULET, Pascale; HALFON, Philippe; POHIER, Eric et al.Journal of clinical microbiology (Print). 2002, Vol 40, Num 6, pp 2031-2036, issn 0095-1137Article

Collection biologique des tumeurs primitives du foie : un trésor de gènes Collection biologique des tumeurs du foie = Biological collection of primary liver tumors: a treasure of genesBALABAUD, Charles; WINNOCK, Maria; CHENE, Geneviève et al.Gastroentérologie clinique et biologique. 2003, Vol 27, Num 12, pp 1076-1078, issn 0399-8320, 3 p.Article

Increase of lipid plasma concentrations under protease inhibitor-containing regimens are not related to modifications of the tumour necrosis factor systemBONNET, Fabrice; SAVES, Marianne; DROZ, Cécile et al.AIDS (London). 2001, Vol 15, Num 7, pp 940-941, issn 0269-9370Article

Effectiveness of health education on Toxoplasma-related knowledge, behaviour, and risk of seroconversion in pregnancyGOLLUB, Erica L; LEROY, Valériane; GILBERT, Ruth et al.European journal of obstetrics, gynecology, and reproductive biology. 2008, Vol 136, Num 2, pp 137-145, issn 0301-2115, 9 p.Article

Mortality in a cohort of hiv-infected adults started on a protease inhibitor-containing therapy standardization to the general populationLEWDEN, Charlotte; RAFFI, Francois; CHENE, Geneviève et al.Journal of acquired immune deficiency syndromes (1999). 2001, Vol 26, Num 5, pp 480-482, issn 1525-4135Article

Survival and prognosis of women with invasive cervical cancer according to ageBRUN, Jean-Luc; STOVEN-CAMOU, Dorothée; TROUETTE, Renaud et al.Gynecologic oncology (Print). 2003, Vol 91, Num 2, pp 395-401, issn 0090-8258, 7 p.Article

Bivariate linear mixed models using SAS proc MIXEDTHIEBAUT, Rodolphe; JACQMIN-GADDA, Hélène; CHENE, Genevieve et al.Computer methods and programs in biomedicine. 2002, Vol 69, Num 3, pp 249-256, issn 0169-2607, 8 p.Article

Penalized likelihood approach to estimate a smooth mean curve on longitudinal dataJACQMIN-GADDA, Hélène; JOLY, Pierre; COMMENGES, Daniel et al.Statistics in medicine. 2002, Vol 21, Num 16, pp 2391-2402, issn 0277-6715, 12 p.Article

Biomarkers of CD4⁺ T-cell activation as risk factors for tuberculosis-associated immune reconstitution inflammatory syndromeCHAKRABARTI, Lisa A; BOUCHERIE, Céline; BUGAULT, Florence et al.AIDS (London). 2014, Vol 28, Num 11, pp 1593-1602, issn 0269-9370, 10 p.Article

Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1:96 week results from the NEAT001/ANRS143 randomised non-inferiority trialRAFFI, François; BABIKER, Abdel G; SAILLARD, Juliette et al.Lancet (British edition). 2014, Vol 384, Num 9958, pp 1942-1951, issn 0140-6736, 10 p.Article

HIV-induced immune deficiency is associated with a higher risk of hepatocarcinoma, ANRS CO3 Aquitaine Cohort, France, 1998―2008BRUYAND, Mathias; DABIS, François; VANDENHENDE, Marie-Anne et al.Journal of hepatology. 2011, Vol 55, Num 5, pp 1058-1062, issn 0168-8278, 5 p.Article

Phase I study of a candidate vaccine based on recombinant HIV-1 gp160 (MN/LAI) administered by the mucosal route to HIV-seronegative volunteers : The ANRS VAC14 studyPIALOUX, Gilles; HOCINI, Hakim; LAUNAY, Odile et al.Vaccine. 2008, Vol 26, Num 21, pp 2657-2666, issn 0264-410X, 10 p.Article